Additional file 2 of Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials

Additional file 2 contains the clinical data of each patient in the study (patient, cohort, onset, gender, age, FRS, NfL levels at baseline, ALSFRS-R at baseline, BMI at baseline, deceased status, months survived since disease onset).

补充文件2包含本研究中每位患者的临床数据，具体包括患者编号、队列、起病时间、性别、年龄、基线FRS水平、基线神经丝轻链（Neurofilament Light Chain, NfL）水平、基线肌萎缩侧索硬化功能评定量表修订版（Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised, ALSFRS-R）评分、基线体质量指数（Body Mass Index, BMI）、死亡状态以及自疾病起病后的存活月数。